These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20805136)

  • 41. Uveal Melanomas Harbor Recurrent Activating Mutations in CYSLTR2.
    Cancer Discov; 2016 Jun; 6(6):573. PubMed ID: 27150534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneity of GNAQ/11 mutation inversely correlates with the metastatic rate in uveal melanoma.
    Liang C; Peng LY; Zou M; Chen X; Chen Y; Chen H; Xiao L; Yan N; Zhang J; Zhao Q; Huang X
    Br J Ophthalmol; 2021 Apr; 105(4):587-592. PubMed ID: 31533929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutation analysis of the PTEN gene in uveal melanoma cell lines.
    Naus NC; Zuidervaart W; Rayman N; Slater R; van Drunen E; Ksander B; Luyten GP; Klein A
    Int J Cancer; 2000 Jul; 87(1):151-3. PubMed ID: 10861467
    [No Abstract]   [Full Text] [Related]  

  • 44. Inactivation of retinoblastoma protein in uveal melanoma by phosphorylation of sites in the COOH-terminal region.
    Brantley MA; Harbour JW
    Cancer Res; 2000 Aug; 60(16):4320-3. PubMed ID: 10969768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PAUPAR lncRNA suppresses tumourigenesis by H3K4 demethylation in uveal melanoma.
    Ding X; Wang X; Lin M; Xing Y; Ge S; Jia R; Zhang H; Fan X; Li J
    FEBS Lett; 2016 Jun; 590(12):1729-38. PubMed ID: 27214741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adipophilin expression in primary and metastatic uveal melanoma: a pilot study.
    Fiorentzis M; Kalirai H; Katopodis P; Coupland SE
    Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):1049-1051. PubMed ID: 28299438
    [No Abstract]   [Full Text] [Related]  

  • 47. Abnormalities of the transforming growth factor-beta pathway in ocular melanoma.
    Myatt N; Aristodemou P; Neale MH; Foss AJ; Hungerford JL; Bhattacharya S; Cree IA
    J Pathol; 2000 Dec; 192(4):511-8. PubMed ID: 11113869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trametinib Induces the Stabilization of a Dual
    Krebs FS; Gérard C; Wicky A; Aedo-Lopez V; Missiaglia E; Bisig B; Trimech M; Michielin O; Homicsko K; Zoete V
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PD-1 expression on uveal melanoma induces tumor proliferation and predicts poor patient survival.
    Jiang Z; Yan Y; Dong J; Duan L
    Int J Biol Markers; 2020 Sep; 35(3):50-58. PubMed ID: 32686562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular pathology of uveal melanoma.
    Coupland SE; Lake SL; Zeschnigk M; Damato BE
    Eye (Lond); 2013 Feb; 27(2):230-42. PubMed ID: 23222563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic determinants of uveal melanoma.
    Kaur J; Malik MA; Gulati R; Azad SV; Goswami S
    Tumour Biol; 2014 Dec; 35(12):11711-7. PubMed ID: 25296731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New prognostic factors in uveal melanomas: potential molecular targets for therapy.
    Saraiva VS; Edelstein C; Burnier MN
    Can J Ophthalmol; 2004 Jun; 39(4):422-7. PubMed ID: 15327108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Uveal melanoma trapped in the temple of doom.
    Shields CL; Ganguly A; O'Brien J; Sato T; Shields JA
    Am J Ophthalmol; 2012 Aug; 154(2):219-21. PubMed ID: 22813447
    [No Abstract]   [Full Text] [Related]  

  • 54. ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity.
    Landreville S; Agapova OA; Kneass ZT; Salesse C; Harbour JW
    Pigment Cell Melanoma Res; 2011 Jun; 24(3):430-7. PubMed ID: 21575142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationships between p53 protein expression and the clinicopathological features in the uveal melanomas.
    Hussein MR
    Cancer Biol Ther; 2005 Jan; 4(1):57-9. PubMed ID: 15662123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histopathologic, immunohistochemical, and cytogenetic analysis of primary clear cell melanoma of the uvea.
    Verdijk RM; Koopmans AE; Kilic E; Paridaens D; de Klein A
    JAMA Ophthalmol; 2013 Jun; 131(6):814-6. PubMed ID: 23579462
    [No Abstract]   [Full Text] [Related]  

  • 57. Minimal contribution of ERK1/2-MAPK signalling towards the maintenance of oncogenic GNAQQ209P-driven uveal melanomas in zebrafish.
    Mouti MA; Dee C; Coupland SE; Hurlstone AF
    Oncotarget; 2016 Jun; 7(26):39654-39670. PubMed ID: 27166257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The ERK signaling pathway returns to the limelight in uveal melanomas.
    Krossa I; Ballotti R; Bertolotto C
    Pigment Cell Melanoma Res; 2021 Sep; 34(5):832-833. PubMed ID: 33548110
    [No Abstract]   [Full Text] [Related]  

  • 59. GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells.
    Pópulo H; Tavares S; Faustino A; Nunes JB; Lopes JM; Soares P
    PeerJ; 2013; 1():e104. PubMed ID: 23904987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Role of MBD4 in hypermutator phenotype and malignant transformation].
    Rodrigues M; Mobuchon L; Houy A; Derrien AC; Fiévet A; Stern MH
    Med Sci (Paris); 2018 Nov; 34(11):925-927. PubMed ID: 30526825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.